Adjuvant Global Health Technology Fund – AN2 Therapeutics, Melioidosis & Tuberculosis Therapeutic (Epetraborole) Global Health Agreement Post author:GHIAA Admin Post published:August 26, 2024 Post category: Continue ReadingAdjuvant Global Health Technology Fund – AN2 Therapeutics, Melioidosis & Tuberculosis Therapeutic (Epetraborole) Global Health Agreement
Gates Foundation – BioNTech, TB & HIV Product Strategic Letter Agreement Post author:GHIAA Admin Post published:July 15, 2024 Post category: Continue ReadingGates Foundation – BioNTech, TB & HIV Product Strategic Letter Agreement
MPP – Gates Medical Research Institute, TB therapeutic (Sutezolid) Sublicense Agreement Post author:GHIAA Admin Post published:May 30, 2024 Post category: Continue ReadingMPP – Gates Medical Research Institute, TB therapeutic (Sutezolid) Sublicense Agreement
Population Council – TherapeuticsMD, Nestorone Contraceptive Ring, License Agreement Post author:GHIAA Admin Post published:March 27, 2024 Post category: Continue ReadingPopulation Council – TherapeuticsMD, Nestorone Contraceptive Ring, License Agreement
MPP (C-TAP) – Biotech Africa, COVID-19 Diagnostic, Patent & Material Sublicense Agreement Post author:GHIAA Admin Post published:January 25, 2024 Post category: Continue ReadingMPP (C-TAP) – Biotech Africa, COVID-19 Diagnostic, Patent & Material Sublicense Agreement
GARDP – Orchid, Cefiderocol Manufacturing Sublicense and Technology Transfer Agreement Post author:GHIAA Admin Post published:November 20, 2023 Post category: Continue ReadingGARDP – Orchid, Cefiderocol Manufacturing Sublicense and Technology Transfer Agreement
Medigen – MPP (C-TAP), COVID-19 Vaccine, Patent and Know How License Agreement Post author:GHIAA Admin Post published:October 10, 2023 Post category: Continue ReadingMedigen – MPP (C-TAP), COVID-19 Vaccine, Patent and Know How License Agreement
University of Chile – MPP (C-TAP), COVID-19 Diagnostic Material & Know-How License Agreement Post author:GHIAA Admin Post published:September 25, 2023 Post category: Continue ReadingUniversity of Chile – MPP (C-TAP), COVID-19 Diagnostic Material & Know-How License Agreement
CSIC – MPP (C-TAP), COVID-19 Vaccine, Patent and Material License Agreement Post author:GHIAA Admin Post published:September 18, 2023 Post category: Continue ReadingCSIC – MPP (C-TAP), COVID-19 Vaccine, Patent and Material License Agreement